| Literature DB >> 17437669 |
Abstract
The absence of Level I evidence undermines the credibility of all clinical studies pertaining to percutaneous vertebral augmentation (ie, kyphoplasty and vertebroplasty). The powerful desire to relieve suffering in the frail elderly cannot substitute for a rigorously designed randomized controlled trial comparing vertebral augmentation with continued nonoperative care. Though the level of available evidence is currently inadequate, its quality is improving.Entities:
Mesh:
Year: 2007 PMID: 17437669 DOI: 10.1007/s11926-007-0023-0
Source DB: PubMed Journal: Curr Rheumatol Rep ISSN: 1523-3774 Impact factor: 4.592